Corbus Pharmaceuticals Announces Resolution of Inflammation, Infection and Tissue Regeneration Conference June 21, 2018
Corbus Pharmaceuticals Presents 1-Year Systemic Sclerosis and 6-Month Dermatomyositis Data from Open-Label Extension of Phase 2 Lenabasum Studies at EULAR 2018 June 13, 2018
Corbus Pharmaceuticals Appoints Former Director of FDA Office of New Drugs John K. Jenkins, MD to Board of Directors June 6, 2018
Corbus Pharmaceuticals Adds Two Key Executives to Lead its Regulatory and CMC Operations May 22, 2018
Corbus Pharmaceuticals Announces Acceptance of Three Abstracts for Presentation at EULAR 2018 Annual Meeting May 15, 2018
Corbus Pharmaceuticals Reports 2018 First Quarter Financial Results and Provides Business Update May 10, 2018
Corbus Pharmaceuticals to Present at the Deutsche Bank 43rd Annual Health Care Conference April 26, 2018
